By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Camurus 

Ideon Science Park
Solvegatan 41
Lund    SE-22370  Sweden
Phone: 46-46-2865730 Fax: 46-46-2865739


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Camurus: Nomination Committee Appointed In Respect Of AGM 2016 In Camurus 2/4/2016 10:10:12 AM
Change In The Number Of Shares And Votes In Camurus 1/7/2016 1:35:23 PM
Rhythm And Camurus Announce License Agreement For Extended Release Fluidcrystal Setmelanotide 1/5/2016 6:38:11 AM
Braeburn Pharma And Camurus Enroll First Patient In A Phase 3 Efficacy Trial Of Long-Acting Treatment For Opioid Dependence 12/30/2015 6:20:38 AM
Camurus: Braeburn Pharma And Camurus Announces Start Of Phase 3 Trial Of Long-Acting Buprenorphine Treatments For Opioid Dependence 12/15/2015 11:23:20 AM
Braeburn Pharma And Camurus Announces Start Of Phase 3 Trial Of Long-Acting Buprenorphine Treatments For Opioid Dependence 12/15/2015 7:27:21 AM
Camurus Appoints Chief Commercial Officer 12/14/2015 9:36:55 AM
Solasia Acquires Exclusive License And Distribution Rights From Camurus For Episil Oral Liquid In Japan And China 3/30/2015 12:04:26 PM
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014 6:02:47 AM
Camurus: Novartis AG (NVS) Exercises Option for CAM2029; Triggers Undisclosed Milestone Payout and Eligible Payments of Up to $700 Million 9/10/2013 7:20:44 AM
12
//-->